Palmetto GBA Executive and Leadership Team

Nancy Lybrand, the Vice President & Chief Financial Officer at Palmetto GBA, directs the financial strategy and fiscal health of the organization. Lybrand manages capital allocation, budgeting, and financial reporting to ensure the company meets its obligations to federal partners and commercial clients. By overseeing revenue cycle management and cost-control initiatives, the Vice President & Chief Financial Officer maintains the financial stability required for high-volume claims processing operations. Nancy Lybrand collaborates with executive leadership to evaluate investment opportunities in new technology and service expansion. This role involves rigorous oversight of financial compliance and risk management, ensuring that all fiscal activities align with government regulations. Through strategic financial planning, Lybrand supports the long-term growth objectives of the company. The Vice President & Chief Financial Officer monitors economic trends and operational costs, providing the necessary data to drive informed decision-making across the entire enterprise, ultimately securing the fiscal future of the organization.

Mike Gurrera, the Vice President & Amp. Chief Financial Officer at Palmetto GBA, manages the operational accounting and financial auditing functions for the company. Gurrera focuses on the precision of transaction-based financial reporting, ensuring that every claim processed meets strict federal accounting standards. By optimizing internal audit processes, the Vice President & Amp. Chief Financial Officer mitigates financial risk and enhances transparency in all government-facing contracts. Mike Gurrera works closely with department heads to align departmental budgets with the broader corporate financial strategy. This leadership role involves analyzing cost structures within contact center operations to identify efficiencies and improve profit margins. Through the implementation of robust financial controls, Gurrera ensures the accuracy of all fiscal data. The Vice President & Amp. Chief Financial Officer provides critical insights into the financial performance of specific service lines, enabling the executive team to allocate resources effectively and maintain a competitive market position.

Margaret Price, the Vice President & Chief Technology Officer at Palmetto GBA, directs the overarching technical strategy for high-volume claims processing systems. Price architects scalable digital infrastructure to support federal government contracts, ensuring maximum uptime and data security across all platforms. By aligning technical roadmaps with evolving federal requirements, the Vice President & Chief Technology Officer optimizes system performance and reliability. Margaret Price manages cross-functional engineering teams to integrate advanced automation into existing transaction workflows, significantly reducing processing latency. This leadership role involves constant collaboration with information security departments to safeguard sensitive client data against emerging cyber threats. Through the implementation of cloud-based solutions and modernized software architectures, Price drives operational efficiency. The Vice President & Chief Technology Officer maintains a focus on long-term technical sustainability, ensuring that Palmetto GBA remains a leader in federal service delivery while meeting complex regulatory demands.

Nella Bishop, the Vice President and Chief Information Officer, Systems and Support at Palmetto GBA, oversees the internal information systems and technical support frameworks essential for daily operations. Bishop manages the deployment of enterprise-wide software solutions that facilitate seamless contact center interactions and claims management. By streamlining internal support processes, the Vice President and Chief Information Officer, Systems and Support ensures that staff possess the necessary tools to maintain high service levels for federal and commercial customers. Nella Bishop coordinates with IT departments to refine system usability and data accessibility, directly impacting the speed of transaction processing. This role involves managing complex system integrations that support the broader organizational mission of operational excellence. Through the continuous improvement of internal support protocols, Bishop enhances the overall productivity of the workforce. The Vice President and Chief Information Officer, Systems and Support secures the integrity of information flows, providing a stable foundation for all corporate activities.

Mark Pilley, the Chief Medical Officer at Palmetto GBA, directs the clinical strategy and medical policy development for the organization. Pilley oversees the interpretation of medical guidelines to ensure that claims processing aligns with current healthcare standards and federal regulations. By providing clinical expertise to the claims review process, the Chief Medical Officer ensures the accuracy and fairness of medical necessity determinations. Mark Pilley collaborates with external healthcare providers and regulatory bodies to maintain compliance with evolving medical policies. This role involves leading clinical teams in the evaluation of complex medical claims, ensuring that all decisions reflect the latest evidence-based practices. Through the development of comprehensive medical review protocols, Pilley enhances the quality of service provided to federal beneficiaries. The Chief Medical Officer serves as the primary clinical authority, guiding the organization in navigating the complexities of the healthcare landscape while maintaining a focus on patient care and regulatory adherence.

Magdalena Karandikar, the Medical Director & Chief Medical Officer, Moldx & Palmetto Gba at Palmetto GBA, leads the clinical assessment of molecular diagnostic testing. Karandikar architects the medical review framework for the MolDX program, ensuring that diagnostic tests meet rigorous clinical utility and validity standards. By evaluating emerging medical technologies, the Medical Director & Chief Medical Officer, Moldx & Palmetto Gba informs coverage policies that impact the broader healthcare market. Magdalena Karandikar manages the clinical review teams responsible for assessing high-complexity diagnostic claims. This role involves extensive engagement with the scientific community to stay at the forefront of molecular diagnostics. Through the application of clinical expertise, Karandikar ensures that diagnostic coverage remains evidence-based and cost-effective. The Medical Director & Chief Medical Officer, Moldx & Palmetto Gba provides the clinical leadership necessary to navigate the rapidly evolving field of precision medicine, ensuring that diagnostic services align with federal quality requirements.

Angella Charnot- Katsikas, the Medical Director & Chief Medical Officer, Moldx at Palmetto GBA, focuses on the clinical oversight of molecular diagnostic coverage policies. Charnot- Katsikas directs the evaluation of laboratory-developed tests to determine clinical appropriateness and reimbursement eligibility. By analyzing clinical data and scientific literature, the Medical Director & Chief Medical Officer, Moldx ensures that the MolDX program maintains high standards for diagnostic accuracy. Angella Charnot- Katsikas collaborates with laboratory directors and clinical experts to refine coverage criteria for new diagnostic technologies. This role involves managing the clinical review process for complex molecular tests, ensuring that all determinations are consistent with federal healthcare policies. Through the application of specialized medical knowledge, Charnot- Katsikas supports the integrity of the diagnostic review process. The Medical Director & Chief Medical Officer, Moldx provides the clinical guidance required to manage the complexities of molecular diagnostics, ensuring that patients receive access to medically necessary testing.

Jacqueline Lekostaj, the Chief Medical Officer, Molecular Diagnostics at Palmetto GBA, oversees the clinical strategy for molecular diagnostic programs. Lekostaj directs the clinical review of diagnostic claims, ensuring that all assessments adhere to established medical necessity guidelines. By evaluating the clinical impact of new diagnostic tools, the Chief Medical Officer, Molecular Diagnostics informs the development of robust coverage policies. Jacqueline Lekostaj manages the clinical teams responsible for the technical assessment of molecular tests, ensuring that all reviews are conducted with precision and scientific rigor. This role involves coordinating with internal and external stakeholders to address clinical challenges in the diagnostic space. Through the application of deep medical expertise, Lekostaj ensures that the organization remains at the forefront of diagnostic policy. The Chief Medical Officer, Molecular Diagnostics provides the clinical leadership necessary to maintain the quality and reliability of diagnostic services, supporting the overall mission of providing accurate and efficient healthcare processing.